Anavex Life Sciences Corp. (AVXL)

4.395 +0.04 (+0.80%) USD  |  NASDAQ  |  Feb 25, 12:48
More

Anavex Life Sciences Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Nephros, Inc. Upgrade
Cabaletta Bio, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Ocugen, Inc. Upgrade